Alpharma Agrees To Talk With King Pharma
Two weeks after rejecting a sweetened bid of $37 a share from King Pharmaceuticals, Alpharma has agreed to talks. (Pharmalot)
The Curator finds, summarizes, and links to the highest-quality, most authoritative online sources of business and political news and information: breaking news, analysis, background and opinion. Learn more »
Have something you'd like to share?
Is there an important story you think we should cover or features you would like added? Let us know »
Two weeks after rejecting a sweetened bid of $37 a share from King Pharmaceuticals, Alpharma has agreed to talks. (Pharmalot)
Categories: Biotech, Pharma · Business & Finance Today
No Comments Yet
You can be the first to comment!
Leave a comment